- All
- 2025-05-22 [Thursday]
- 2025-05-23 [Friday]
- 2025-05-24 [Saturday]
- All
- Board Room, 2F
- Tulip Ballroom, 2F
- Tulip Ballroom 1, 2F
- Tulip Ballroom 2, 2F
- Magnolia Room, 2F
- Jasmine Room, 2F
- Red Maple Room, 1F
2025-05-23 Friday
Tulip Ballroom 2, 2F (UTC+8) 2025-05-23 Local Time
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | |
|---|---|---|---|---|---|---|
| 1 | 13:20-13:35 | 13:20-13:35 | Plenary Lecture |
Melanocyte, the original sin of alopecia areata and vitiligo |
Xiuzu Song | |
| 2 | 13:35-13:50 | 13:35-13:50 | Plenary Lecture |
Innovative Approaches in Vitiligo: Integrating AI-assisted Imaging, Biomarkers, and Targeted Therapy |
Chau Yee Ng | |
| 3 | 13:50-14:05 | 13:50-14:05 | Plenary Lecture |
Treatment of refractory progressive vitiligo with oral upadacitinib plus phototherapy |
Yonghu Sun | |
| 4 | 14:05-14:20 | 14:05-14:20 | Plenary Lecture |
Personalized approaches to vitiligo care enhancing outcomes in clinical practice |
Jung Min Bae | |
| 5 | 14:20-14:35 | 14:20-14:35 | Plenary Lecture |
Novel perspective in understanding Vitiligo: A Preliminary Study on Melanocyte Immunogenicity |
Wei Zhang | |
| 6 | 14:35-14:50 | 14:35-14:50 | Plenary Lecture |
Clinical markers and biomarkers of vitiligo: A latest update |
Chengfeng Zhang | |
| 7 | 14:50-15:00 | 14:50-15:00 | Comment |
Q&A |
||
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker |
|---|---|---|---|---|---|
| 1 | 15:00-15:20 | 15:00-15:20 | Symposium |
白癜风诊疗进展 |
Chengfeng Zhang |
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker |
|---|---|---|---|---|---|
| 1 | 15:35-15:55 | 15:35-15:55 | Symposium |
An upgraded IL-17 inhibitor with a dual-excellent structure of both fully human and IgG4 subtypes The outstanding clinical value of independently developed IL-17A inhibitor |
Nan Xu |
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | |
|---|---|---|---|---|---|---|
| 1 | 15:55-16:05 | 15:55-16:05 | Plenary Lecture |
Responsiveness of oral mini-pulse methylprednisolone (OMP): a comparison of vitiligo in children and adolescents versus adults |
Mengmeng Geng | |
| 2 | 16:05-16:15 | 16:05-16:15 | Oral Presentation |
Risk Factors for Recurrence in Vitiligo Vulgaris: Insights from a Large-Scale Cohort on Phenotypic and Autoimmune Predictors |
Hsin Yu Shih | |
| 3 | 16:15-16:25 | 16:15-16:25 | Oral Presentation |
A Study of Noncultured Extracted Hair Follicle Outer Root Sheath Cell Suspension for Transplantation in Stable Vitiligo |
Fang Yan | |
| 4 | 16:25-16:35 | 16:25-16:35 | Oral Presentation |
Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: A 52-week prospective study |
Yijie Xuan | |
| 5 | 16:35-16:45 | 16:35-16:45 | Oral Presentation |
Autologous Cultured Tissue Engineering Epidermal Sheet Transplantation to Treat Childhood Vitiligo |
Jian Li | |
| 6 | 16:45-16:55 | 16:45-16:55 | Oral Presentation |
Analysis of Long-term Follow-up Efficacy of Autologous Cultured Melanocyte Transplantation in the Treatment of Vitiligo |
Lei Wang | |
| 7 | 16:55-17:05 | 16:55-17:05 | Comment |
Q&A |
||
